Relevant bibliographies by topics / Hepatorenalt syndrom / Dissertations / Theses
To see the other types of publications on this topic, follow the link: Hepatorenalt syndrom.

Dissertations / Theses on the topic 'Hepatorenalt syndrom'

Author: Grafiati
Published: 4 June 2021
Last updated: 7 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 16 dissertations / theses for your research on the topic 'Hepatorenalt syndrom.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Svantesson, Elise. "Hepatorenalt syndrom : Rådande teorier om patomekanismer och terlipressins plats i behandlingen." Thesis, Umeå universitet, Farmakologi, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136456.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Anand, Radhika Saraswattie. "A model of hepatorenal syndrome." Thesis, University College London (University of London), 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.405754.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Huber, Elisabeth. "Pharmakotherapie des hepatorenalen Syndroms." Diss., lmu, 2009. http://nbn-resolving.de/urn:nbn:de:bvb:19-108990.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Koch, Nikolaus Heinrich [Verfasser], Wolfgang L. E. [Akademischer Betreuer] Huber, Wolfgang L. E. [Gutachter] Huber, and Roland M. [Gutachter] Schmid. "Eine randomisierte kontrollierte Studie zur zielgerichteten Therapie des hepatorenalen Syndroms (Early goal-directed volume resuscitation in hepatorenal syndrome (RACEHORSE)) / Nikolaus Heinrich Koch ; Gutachter: Wolfgang L. E. Huber, Roland M. Schmid ; Betreuer: Wolfgang L. E. Huber." München : Universitätsbibliothek der TU München, 2020. http://d-nb.info/121529333X/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Snowdon, Victoria Katherine. "Relaxin as a therapeutic haemodynamic modulator in liver disease." Thesis, University of Edinburgh, 2016. http://hdl.handle.net/1842/23508.

Full text
Abstract:
Introduction: Hepatorenal syndrome (HRS) is a common complication of advanced cirrhosis with a high mortality rate and limited treatment options. Central to its pathogenesis is severe, but potentially reversible, renal vasoconstriction leading to functional renal failure. Current pharmacological treatment using splanchnic vasoconstrictors is suboptimal and prognosis without liver transplantation is dismal. The peptide hormone relaxin (RLN) mediates haemodynamic adaptations to pregnancy including increased renal blood flow (RBF) and glomerular filtration rate (GFR). I hypothesised that exogenou
APA, Harvard, Vancouver, ISO, and other styles
6

Glowa, Fabian [Verfasser], and Ulrike [Akademischer Betreuer] Denzer. "Terlipressin in der Behandlung des hepatorenalen Syndroms : Eine klinische Evaluation / Fabian Glowa. Betreuer: Ulrike Denzer." Hamburg : Staats- und Universitätsbibliothek Hamburg, 2011. http://d-nb.info/1020458135/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Austgen, Thomas [Verfasser]. "Die klinische Bedeutung von Biomarkern des Zelltodes und der Inflammation bei Patienten mit Leberzirrhose und hepatorenalem Syndrom / Thomas Austgen." Mainz : Universitätsbibliothek der Johannes Gutenberg-Universität Mainz, 2021. http://d-nb.info/1237814626/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Tonsen, Marie-Thérèse [Verfasser]. "Behandlung des hepatorenalen Syndroms mit Terlipressin und Humanalbumin bei Patienten mit Leberzirrhose und Auswirkungen auf die Lebertransplantation / Marie-Thérèse Tonsen." Mainz : Universitätsbibliothek der Johannes Gutenberg-Universität Mainz, 2020. http://d-nb.info/1224810732/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kühnel, Markus. "Diagnostische Wertigkeit der fraktionellen Harnstoffexkretion, des Serum Cystatin C, sowie der glomerulären Filtrationsrate nach MDRD zur Detektion eines hepatorenalen Syndroms bei Leberzirrhose." kostenfrei, 2008. http://www.opus-bayern.de/uni-regensburg/volltexte/2009/1127/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Martín, Llahí Marta. "Estudis sobre la insuficiència renal en la cirrosi hepàtica: Anàlisi del pronòstic i investigació en el tractament farmacològic de la síndrome hepatorenal." Doctoral thesis, Universitat de Barcelona, 2013. http://hdl.handle.net/10803/116494.

Full text
Abstract:
Des que es va definir la síndrome hepatorenal (SHR), als anys 60 del segle passat, s’han fet grans progressos en el coneixement d’aquesta entitat. La SHR és una insuficiència renal característica dels pacients amb cirrosi hepàtica (CH) amb molt mal pronòstic a curt plaç. El tractament curatiu és el trasplantament hepàtic perquè elimina la CH que és l’origen del problema. Però no sempre està indicat el trasplantament o no s’arriba a temps de realitzar-lo. Els estudis basats en la fisiopatologia de la SHR han estat la base per investigar sobre tractaments que puguin revertir la insuficiència ren
APA, Harvard, Vancouver, ISO, and other styles
11

Rodríguez, Gullello Ezequiel Alejandro. "Insuficiencia renal en la cirrosis: Evaluación de nuevas clasificaciones pronósticas y tratamiento del síndrome hepato-renal tipo 1 asociado a sepsis." Doctoral thesis, Universitat de Barcelona, 2015. http://hdl.handle.net/10803/312148.

Full text
Abstract:
El objetivo general de esta Tesis Doctoral es profundizar en el conocimiento sobre la insuficiencia renal, una complicación frecuente y asociada a mal pronóstico que pueden presentar los pacientes con cirrosis hepática. Los trabajos diseñados para tal objetivo están enfocados por un lado, a investigar la capacidad predictiva de mortalidad de la clasificación de pacientes acorde al grado de ACLF sobre la clasificación AKIN y a evaluar eficacia y seguridad del tratamiento con vasoconstrictores de los pacientes con SHR tipo-1 y sepsis asociada . El resultado principal del primer estudio fue que
APA, Harvard, Vancouver, ISO, and other styles
12

Ximenes, Rafael Oliveira. "Biomarcador urinário NGAL em pacientes com cirrose: acurácia diagnóstica para predizer desenvolvimento ou progressão da lesão renal aguda e resposta ao tratamento da síndrome hepatorrenal." Universidade de São Paulo, 2017. http://www.teses.usp.br/teses/disponiveis/5/5168/tde-31072017-121023/.

Full text
Abstract:
INTRODUÇÃO: Lesão renal aguda (LRA) é uma complicação comum da cirrose frequentemente desencadeada por infecções bacterianas. A mortalidade de pacientes com cirrose e LRA varia de 10 a 100% a depender do estádio da cirrose, etiologia e progressão da LRA e tratamento recebido. Pacientes com LRA que progride possuem mortalidade intra-hospitalar consideravelmente maior do que aqueles que não progridem. Os critérios diagnósticos da LRA baseiam-se na creatinina sérica. Porém, esse biomarcador tem acurácia diagnóstica limitada, já que demora até 48 horas para se alterar e não distingue a etiologia d
APA, Harvard, Vancouver, ISO, and other styles
13

Ping, Tseng Hsu, and 曾旭平. "Treatment of type I hepatorenal syndrome with octreotide and dopamine." Thesis, 2002. http://ndltd.ncl.edu.tw/handle/79031842148784702940.

Full text
Abstract:
碩士<br>中國醫藥學院<br>醫學研究所<br>90<br>Background Hepatorenal syndrome (HRS), a clinical condition that occurs in cirrhotic patients with advanced hepatic failure and portal hypertension, is characterized by impaired renal function and marked abnormalities in the arterial circulation and activity of the endogenous vasoactive systems. The prognosis of HRS is very poor and there is no satisfactory medical treatment. According to the arterial vasodilatation theory, splanchnic vasodilatation (due to portal hypertension) has been considered to be the start point of HRS. Therefore, volume expansion and va
APA, Harvard, Vancouver, ISO, and other styles
14

Zielinski, Julia [Verfasser]. "Inzidenz, Prognosefaktoren und Behandlungsoptionen des hepatorenalen Syndroms / vorgelegt von: Julia Zielinski." 2008. http://d-nb.info/992298326/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Huber, Elisabeth [Verfasser]. "Pharmakotherapie des hepatorenalen Syndroms : klinische Ergebnisse der kontinuierlichen Terlipressin-Applikation / vorgelegt von Elisabeth Huber." 2009. http://d-nb.info/999774492/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Kühnel, Markus [Verfasser]. "Diagnostische Wertigkeit der fraktionellen Harnstoffexkretion, des Serum Cystatin C, sowie der glomerulären Filtrationsrate nach MDRD zur Detektion eines hepatorenalen Syndroms bei Leberzirrhose / vorgelegt von Markus Kühnel." 2009. http://d-nb.info/992296498/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Hepatorenalt syndrom' for other source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography